Palantir is a strong buy with booming AI platforms, 29% revenue growth, and strategic positioning in the AI arms race. Click ...

The tariff pause has temporarily stabilized markets, but underlying issues & high volatility persist. Find out why interest ...

Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

Alcoa's stock is down ~75% from its ATH. Tariff wars and economic uncertainty added fuel to the fire, but Q1 2025 results ...

CLOs posted positive Q1 total returns as spreads widened and market volatility grew. Amid trade tensions and signs of ...

Metro has been outperforming the market during these volatile times, and its Q2 results were relatively strong. Find out why ...

MSCI's asset-light business model, high client switching costs, and minimal tariff impact make it a preferred investment ...

El Al Israel Airlines soared 45.5% amid regional demand, with 2024 revenues at $3.4B. Explore growth, risks, and the updated ...

At a market cap of 4.7B EUR and EV/EBITDA of 4.8, Arkema is attractively priced, even with a potential 15% EBITDA reduction.

When markets move, we can learn a lot from the outperformers. But we can also learn a lot from the underperformers - and ...

KREF's Series A is attractively priced for a company with a credit rating of B+. Though current yields of near 9% exist, ...

Adriatic Metals PLC upgraded to Buy due to Vareš project ramp-up, expected commercial production in Q1 2025, and favorable ...